Edgewise Therapeutics Inc (EWTX)
19.52
+0.23
(+1.19%)
USD |
NASDAQ |
May 03, 16:00
19.48
-0.04
(-0.20%)
After-Hours: 20:00
Edgewise Therapeutics Price to Book Value: 5.701 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 5.701 |
| May 02, 2024 | 5.633 |
| May 01, 2024 | 5.552 |
| April 30, 2024 | 5.239 |
| April 29, 2024 | 4.979 |
| April 26, 2024 | 4.722 |
| April 25, 2024 | 4.655 |
| April 24, 2024 | 4.705 |
| April 23, 2024 | 4.570 |
| April 22, 2024 | 4.404 |
| April 19, 2024 | 4.448 |
| April 18, 2024 | 4.512 |
| April 17, 2024 | 4.570 |
| April 16, 2024 | 4.857 |
| April 15, 2024 | 4.813 |
| April 12, 2024 | 4.781 |
| April 11, 2024 | 4.816 |
| April 10, 2024 | 4.652 |
| April 09, 2024 | 4.728 |
| April 08, 2024 | 4.930 |
| April 05, 2024 | 4.953 |
| April 04, 2024 | 4.824 |
| April 03, 2024 | 5.403 |
| April 02, 2024 | 5.160 |
| April 01, 2024 | 5.262 |
| Date | Value |
|---|---|
| March 28, 2024 | 5.327 |
| March 27, 2024 | 5.245 |
| March 26, 2024 | 5.006 |
| March 25, 2024 | 4.673 |
| March 22, 2024 | 4.746 |
| March 21, 2024 | 4.932 |
| March 20, 2024 | 4.898 |
| March 19, 2024 | 4.728 |
| March 18, 2024 | 4.535 |
| March 15, 2024 | 4.941 |
| March 14, 2024 | 4.985 |
| March 13, 2024 | 5.084 |
| March 12, 2024 | 5.175 |
| March 11, 2024 | 4.892 |
| March 08, 2024 | 5.011 |
| March 07, 2024 | 5.181 |
| March 06, 2024 | 4.965 |
| March 05, 2024 | 4.956 |
| March 04, 2024 | 4.965 |
| March 01, 2024 | 4.874 |
| February 29, 2024 | 4.769 |
| February 28, 2024 | 4.862 |
| February 27, 2024 | 4.921 |
| February 26, 2024 | 4.976 |
| February 23, 2024 | 5.046 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.080
Minimum
May 25 2022
5.832
Maximum
Feb 07 2024
2.479
Average
1.990
Median
Jan 27 2023
Price to Book Value Benchmarks
| Sarepta Therapeutics Inc | 13.14 |
| PTC Therapeutics Inc | -- |
| Fate Therapeutics Inc | 1.094 |
| Viking Therapeutics Inc | 9.088 |
| Regenxbio Inc | 2.645 |
Price to Book Value Related Metrics
| Price | 19.52 |
| Earnings Yield | -8.09% |
| Market Cap | 1.818B |